| Company Name: |
Hangzhou Peptidego Biotech Co.,Ltd.
|
| Tel: |
0571-87213919 |
| Email: |
Eric@peptidego.com |
| Products Intro: |
Product Name:MK2-IN-5 CAS:474713-20-7 Purity:95% or 98% HPLC Package:1mg;5mg;10mg;50mg;100mg,1g or according to customer's detail requirement.
|
| Company Name: |
Hangzhou Go Top Peptide Biotech
|
| Tel: |
0571-88211921 17357109671 |
| Email: |
sales3@gotopbio.com |
| Products Intro: |
CAS:474713-20-7 Purity:研发级,98%,HPLC,MS Package:9g
|
| Company Name: |
Hangzhou Sinoda Pharmaceutical Technology Co. LTD
|
| Tel: |
0571-87213919 17306812703 |
| Email: |
3007955328@qq.com |
| Products Intro: |
Product Name:MK2-IN-5 CAS:474713-20-7 Purity:95% or 98% HPLC Package:1mg;5mg;10mg;50mg;100mg,1g or according to customer's detail requirement.
|
|
| | L-Lysyl-L-lysyl-L-lysyl-L-alanyl-L-leucyl-L-asparaginyl-L-arginyl-L-glutaminyl-L-leucylglycyl-L-valyl-L-alanyl-L-alanine Basic information |
| | L-Lysyl-L-lysyl-L-lysyl-L-alanyl-L-leucyl-L-asparaginyl-L-arginyl-L-glutaminyl-L-leucylglycyl-L-valyl-L-alanyl-L-alanine Chemical Properties |
| density | 1.40±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted) | | pka | 3.43±0.10(Predicted) | | Sequence | Lys-Lys-Lys-Ala-Leu-Asn-Arg-Gln-Leu-Gly-Val-Ala-Ala |
| | L-Lysyl-L-lysyl-L-lysyl-L-alanyl-L-leucyl-L-asparaginyl-L-arginyl-L-glutaminyl-L-leucylglycyl-L-valyl-L-alanyl-L-alanine Usage And Synthesis |
| Uses | MK2-IN-5 is a Mk2 pseudosubstrate (Ki= 8 μM). MK2-IN-5 targets the protein interaction domain in the MAPK pathway. MK2-IN-5 inhibits HSP25 and HSP27 phosphorylation[1][2][3]. | | in vivo | MK2-IN-5 (2 mg/kg Intraperitoneal injection, single dose) decreased HSP25 phosphorylation in ventilator-associated lung injury model[2]. | Animal Model: | ventilator-associated lung injury model[2] | | Dosage: | 2 mg/kg | | Administration: | Intraperitoneal injection (i.p.) | | Result: | Decreased HSP25 phosphorylation. |
| | IC 50 | ERK1; ERK2 | | References | [1] Gaestel M, et al. Peptides as signaling inhibitors for mammalian MAP kinase cascades [J]. Current pharmaceutical design, 2009, 15(21): 2471-2480. DOI:10.2174/138161209788682299 [2] Damarla M, et al. Mitogen activated protein kinase activated protein kinase 2 regulates actin polymerization and vascular leak in ventilator associated lung injury [J]. PloS one, 2009, 4(2): e4600. DOI:10.1371/journal.pone.0004600 [3] Lopes L B, et al. Inhibition of HSP27 phosphorylation by a cell-permeant MAPKAP Kinase 2 inhibitor [J]. Biochemical and biophysical research communications, 2009, 382(3): 535-539. DOI:10.1016/j.bbrc.2009.03.056 |
| | L-Lysyl-L-lysyl-L-lysyl-L-alanyl-L-leucyl-L-asparaginyl-L-arginyl-L-glutaminyl-L-leucylglycyl-L-valyl-L-alanyl-L-alanine Preparation Products And Raw materials |
|